CDC COCA Call: Molecular Approaches for Clinical and Public Health Applications to Detect Influenza and SARS-CoV-2 Viruses
December 9, 2021 –
During this COCA Call, clinicians will learn critical information about molecular approaches for clinical and public health applications to detect the influenza virus and SARS-CoV-2, the virus that causes COVID-19. Presenters from the Centers for Disease and Prevention (CDC) will review the most up to date guidance on clinical testing for influenza, including situations when influenza and SARS-CoV-2 are co-circulating in a community or other setting. In addition, presenters will provide in-depth discussion on cycle threshold (Ct) values from SARS-CoV-2 diagnostic assays and their correlation with viral load and infectiousness. Presenters will also discuss SARS-CoV-2 sequencing applications for public health.
Presenters
Manish Patel, MD, MSc, Team Lead, Influenza Prevention and Control Team, Influenza Division, Centers for Disease Control and Prevention
John Barnes, PhD, Team Lead, Strain Surveillance and Emerging Variants, COVID-19 Response, Centers for Disease Control and Prevention
John T. Brooks, MD, Senior Science Advisor, COVID-19 Response, Centers for Disease Control and Prevention
Webinar Link: https://www.zoomgov.com/j/1609262149
Passcode: 274605
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1609262149#,,,,*274605# or +16468287666,,1609262149#,,,,*274605#
Webinar ID: 160 926 2149